文献速递免疫规划卫生政策与健康促进妇幼与学校卫生

香港引入基于年龄/孕期的儿童和孕妇普遍流感疫苗接种规划的项目成本

Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
PubMed 文献 · Vaccine · 2021-10-30

本研究从政府视角估算香港按儿童年龄和孕妇孕期实施全年常规流感疫苗接种规划的增量成本,并与现行季节性疫苗接种补贴计划(VSS)比较。采用WHO Flutool Plus模型,基于文献、公开数据和专家意见,结果显示常规全年接种规划相比VSS可能节省成本。

要点

  • 6月龄至2岁儿童接种三剂流感疫苗在75%覆盖率下年增量成本为1,175,146美元(每剂成本10.55美元)。
  • 孕妇接种一剂在60%覆盖率下年增量成本为398,555美元(每剂成本13.39美元)。
  • 实施常规免疫规划的总成本为1,573,701美元,占香港年度医疗支出的0.012%。

核心结论

  • 按儿童年龄或孕妇孕期提供全年普遍流感疫苗接种规划,相比现行季节性补贴疫苗接种规划,预测可节省成本。

研究设计与样本

  • 使用世界卫生组织Flutool Plus模型,从政府视角估算2021年对6月龄至2岁儿童和孕妇接种流感疫苗的年度增量成本;输入基于文献综述、公开数据和专家意见;敏感性分析涵盖不同覆盖率和疫苗成本。

主要发现

  • 在75%覆盖率下,儿童接种三剂流感疫苗的年度增量成本(含疫苗价格)为1,175,146美元,每剂成本10.55美元。
  • 在60%覆盖率下,孕妇接种一剂的年度增量成本为398,555美元,每剂成本13.39美元。
  • 对两组风险人群同时实施常规免疫规划的总成本为1,573,701美元,占香港年度医疗支出的0.012%。
  • 在多项敏感性分析中,预测全年常规接种规划相比VSS可节省政府成本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hong Kong experiences year-round influenza activity with winter and summer peaks. The government's Vaccination Subsidy Scheme (VSS) provides vaccine to high-risk groups prior to the larger winter peak. The VSS is predominantly administered through the private sector. This study aimed to cost the two theoretical routine influenza vaccination schedules using both northern and southern hemisphere vaccines, administered according to child's age and women's gestation, from a governmental perspective; and compare these costs to the costs of government's seasonal VSS assuming equivalent coverage estimates to determine the budget impacts of these influenza vaccination programmes in Hong Kong. METHODS: We used the World Health Organization's Flutool Plus to estimate the incremental annual costs for immunising young children aged 6 months to 2 years and pregnant women with influenza vaccine during 2021, assuming the latter group accesses the public system for some antenatal care. Inputs were based on literature review, publicly available data and expert opinions. Sensitivity analyses were done with various coverage rates and vaccine costs. RESULTS: The annual incremental cost (including vaccine price) to vaccinate young children with three doses of influenza vaccine during the first two years of life was estimated at USD 1,175,146 (per-dose-cost of USD 10.55) at 75% coverage while that to vaccinate pregnant women with one dose at 60% coverage was estimated at USD 398,555 (per-dose-cost of USD 13.39). Across a range of sensitivity analyses we predict that routine year-round schedules could be cost-saving to the government compared to the VSS. Implementing routine immunisation to both risk groups equates to USD 1,573,701, i.e., 0.012% of Hong Kong's annual healthcare spending. CONCLUSION: Proposed year-round universal schedules providing influenza immunisation according to the child's age or the woman's gestation are predicted to be cost-saving compared to the current seasonally administered subsidised vaccine programme.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. de Haas TDJ, Yeung KHT, Hutubessy R, et al. Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong. Vaccine. 2021. PMID: 34743828. doi:10.1016/j.vaccine.2021.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。